三阴性乳腺癌组织中肿瘤干细胞相关标记物CD44+/CD24—/low和ALDH1+的表达及意义(4)
[15] Liedtke C，Mazouni C，Hess K R，et al.Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer[J].J Clin Oncol，2008，26(8)：1275-1281.[16] Tischkowitz M，Brunet J S，Begin L R，et al.Use of immunohistochemical markers can refine prognosis in triple negative breast cancer[J].BMC Cancer ......
您现在查看是摘要页，全文长 2204 字符。